Phenylbutazone and its derivatives with special reference to G.27202.
作者信息
HART F D, BURLEY D
出版信息
Br Med J. 1959 Apr 25;1(5129):1087-9. doi: 10.1136/bmj.1.5129.1087.
Abstract
摘要
相似文献
1
Phenylbutazone and its derivatives with special reference to G.27202.保泰松及其衍生物，特别提及G.27202
Br Med J. 1959 Apr 25;1(5129):1087-9. doi: 10.1136/bmj.1.5129.1087.
2
3
[Comparative toxicity of various phenylbutazone derivatives].[各种保泰松衍生物的比较毒性]
C R Seances Soc Biol Fil. 1961;155:1419-20.
4
The status of G-27202 (metabolite 1 of phenylbutazone) in the treatment of rheumatic disorders.G-27202（保泰松代谢物1）在风湿性疾病治疗中的地位。
Can Med Assoc J. 1960 May 14;82(20):1005-8.
5
[Effect of some phenylbutazone derivatives on various edematous reactions in the rat].[某些保泰松衍生物对大鼠各种水肿反应的影响]
C R Seances Soc Biol Fil. 1960;154:2383-6.
6
[The influence of some phenylbutazone derivatives on the phenol red blood level in the rat].[某些保泰松衍生物对大鼠酚红血药浓度的影响]
Med Exp Int J Exp Med. 1959;1:285-9.
7
8
[Phenylbutazone derivatives and duodenal extrabulbar ulcer].[保泰松衍生物与十二指肠球外溃疡]
Wiad Lek. 1979 Dec 1;32(23):1707-10.
9
[About the glucoside of 1,2-diphenyl-3,5-dioxo-4-n-butyl-pyrazolidine (phenylbutazone)].关于1,2 - 二苯基 - 3,5 - 二氧代 - 4 - 正丁基 - 吡唑烷（保泰松）的糖苷
Experientia. 1958 Aug 15;14(8):294-5. doi: 10.1007/BF02167008.
10
[G-28315 in gout].[痛风中的G - 28315]
Rev Rhum Mal Osteoartic. 1960 Jan-Feb;27:39-43.
引用本文的文献
1
TRIAL OF NIFENAZONE ("THYLIN").尼芬那宗（“噻啉”）试验。
Br Med J. 1964 Jun 13;1(5397):1553-4. doi: 10.1136/bmj.1.5397.1553.
2
Effects of oxyphenbutazone (tandearil) on plasma seromucoids. II. In postoperative inflammation.羟苯丁酮（坦得明）对血浆血清类黏蛋白的影响。II. 术后炎症情况
Can Med Assoc J. 1963 Mar 23;88(12):606-10.
3
Effects of oxyphenbutazone (Tandearil) on plasma seromucoids. I. In experimental inflammation.羟苯丁酮（坦得静）对血浆血清类黏蛋白的影响。I. 实验性炎症方面
Can Med Assoc J. 1963 Mar 16;88(11):562-7.
4
Hydroxy-phenylbutazone (Tanderil) in the treatment of ocular disease. A preliminary survey.羟基保泰松（坦德瑞）治疗眼部疾病的初步调查。
Br J Ophthalmol. 1960 Dec;44(12):755-60. doi: 10.1136/bjo.44.12.755.
5
A controlled trial of phenylbutazone, oxyphenbutazone, and a placebo in the treatment of rheumatoid arthritis.
Ann Rheum Dis. 1961 Jun;20(2):161-72. doi: 10.1136/ard.20.2.161.
6
Chronic duodenal obstruction: a mechano-vascular etiology of pancreatitis. II. Experimental observations.慢性十二指肠梗阻：胰腺炎的一种机械性血管病因。II. 实验观察
Am J Dig Dis. 1960 Dec;5:1006-18. doi: 10.1007/BF02231945.
7
A preliminary report of the anti-inflammatory effect of oxyphenbutazone (G27202) in postoperative obstetrical and gynecological practice.
Can Med Assoc J. 1961 Aug 5;85(6):295-8.
8
Pyrazolidines in the treatment of gout.吡唑烷类药物在痛风治疗中的应用
Can Med Assoc J. 1968 Nov 30;99(21):1038-43.
本文引用的文献
1
The status of phenylbutazone (butazolidin) in the treatment of rheumatic disorders.保泰松（布他唑立丁）在风湿性疾病治疗中的地位。
Can Med Assoc J. 1958 Oct 15;79(8):634-8.
2
Value of uricosuric agents and in particular of G. 28 315 in gout.促尿酸排泄剂尤其是G. 28 315在痛风治疗中的价值。
Ann Rheum Dis. 1958 Sep;17(3):326-33. doi: 10.1136/ard.17.3.326.
3
The present status of phenylbutazone therapy in rheumatic disease.保泰松治疗风湿性疾病的现状
Practitioner. 1958 Jul;181(1081):23-8.
4
Phenylbutazone metabolites: antirheumatic, sodium-retaining and uricosuric effects in man.保泰松代谢产物：对人体的抗风湿、保钠及促尿酸排泄作用
J Pharmacol Exp Ther. 1958 May;123(1):63-9.
5
Evaluation of uricosuric agents in chronic gout.慢性痛风中促尿酸排泄剂的评估
Ann Rheum Dis. 1957 Dec;16(4):425-37. doi: 10.1136/ard.16.4.425.
6
The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material.保泰松（布他唑立丁）在人体中的生理处置及其在生物材料中的测定方法。
J Pharmacol Exp Ther. 1953 Nov;109(3):346-57.
7
RICKARD CHRISTOPHERS, 80.里卡德·克里斯托弗斯，80岁。
Br Med J. 1953 Nov 28;2(4847):1214-5.
Zotero 插件